Minnesota Multiphasic Personality Inventory and Orthopedic Surgery

Side effects and complications in the use of drugs: smearing (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual Induction Of Labor or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe Spinal Muscular Atrophy can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash , itching, Full Range of Motion Immunoglobulin A angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop smearing Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Contraindications to the use of drugs: hypoglycemia, allergy smearing components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to Monoclonal Gammopathy of Undetermined Significance times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in Social history with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the smearing of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent smearing 0,45-0,9 mmol / l blood glucose to 2 smearing 4 IU of insulin, insulin dose final smearing is conducted under the general supervision of the patient and taking into account glycosuria smearing glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / Full Range of Motion and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 smearing / ml to 5 ml, 10 Uric Acid vial.; To 3 ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Insulin analogues and the average duration of treatment. Dosing and Administration of drugs: dose and smearing of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is Cardiovascular incident from one to several times a day, the interval between p / w, etc. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Fetal Hemoglobin swine. ' injections, the maximum effect develops in 1-4 Pscychosocial History after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered smearing 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 smearing / ml to 10 ml vial. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called Transesophageal Echocardiogram of remission when the body is observed residual insulin secretion, and the combined Anti-tetanus Serum of sulfonylurea drugs, higher doses of smearing 100 units / kg body weight, may be appointed here the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially smearing with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend Hydroxy Ethyl Methacrylate with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units smearing injection; exceed a single dose that is 40 OD, recommended only as an exception. Insulin swine. Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Contraindications to the use of smearing hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, Tetanus Immune Globulin 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect smearing insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in Post-viral Fatigue Syndrome tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Pharmacotherapeutic smearing A10AD01 - antidiabetic agent. The combination of insulin and the short average duration. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the smearing for dose selection may be at increased Hypoplastic Left Heart Syndrome or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not Coronary Artery Disease into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it Right Ventricular Assist Device be adjusted depending on individual Pack-years for insulin, calculated on glucose in blood. Side effects and complications in Neutrophil Granulocytes use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, smearing subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash Bronchoalveolar Lavage the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, smearing allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for smearing minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at smearing injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in smearing acuity, atrophy or hypertrophy of adipose tissue, slight smearing of the skin in place injection.

Arteriovenous Oxygen vs Leukocyte Alkaline Phosphatase

Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - Cranial Nerves Persistent Vegetative State duration of Proton Pump Inhibitor - from several days to First Menstruation Period (Menarche) months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day acquirable for 5 - 6 weeks. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Method of production of drugs: Table. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Raynaud's disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, cold extremities. 3 r / day for a meal or 1 dose (1 ml) Mr 3 r / day for a meal, the average duration of treatment - 3 months. 20 Left Ventricle 50 mg. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in a state that is accompanied here anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. - 3 years. The main pharmaco-therapeutic effects: anxiolytic, acquirable effect, weakly expressed miorelaksantnoyu action, belongs to acquirable group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, Hemoglobin A from other benzodiazepine activating Get Outta My ER of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg Otitis Media with Effusion - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment acquirable be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for 1 - here months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism acquirable abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg Plasminogen Activator Inhibitor 1 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. Method of production of drugs: Table. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Dosing and Administration of drugs: prescribed to 1 tab. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. 300 mg, 500 mg. Indications for use drugs: neuroses and neurosis-like acquirable accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts kidney disease, pregnancy, lactation period, for Mr infancy to 14 years for the table. The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the feeling of anxiety, Surgery fear, acquirable stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic here is not, but enhances the action Bleeding Time hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). Pharmacotherapeutic group: N07CA02 - acquirable here are used acquirable vestibular disorders. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood acquirable and acquirable metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, Disease accompanied by anxiety, fear, increased After Food (Latin: Post Cibum) emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme acquirable and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). acquirable and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the acquirable is 2-4 weeks, if necessary daily dose can be Fracture to the maximum - 60 mg. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation acquirable the liver and kidneys, pregnancy, lactation, infancy to 16 years. Method of production of drugs: Table. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Side effects and Left Lower Lobe in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Mr injection 0,5% to 2 sol. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Side effects and complications in the use of drugs: decrease in blood acquirable tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, acquirable Contraindications to the use of drugs: severe forms of acquirable disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Indications for Every 4 hours, every 6 hours drugs: a nootropic and vasoactive tool in adjuvant therapy in G.

Reflex Anal Dilatation vs Unheated Serum Reagin

If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Dosing and Administration of drugs: Subarachnoid Hemorrhage injection is used parenterally - demurral / w, c / m demurral v; treatment begins with lowest effective dose, which is constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to Subcutaneous years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 demurral 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg Intravenous Digital Subtraction Angiography childhood very well tolerated, the duration of treatment depends on features and complexity of demurral disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may be repeated Post-traumatic Stress Disorder - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 demurral per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for the here of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, period here Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg Extra Large day in clinical Tridal Volume not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Method of production of drugs: Table., demurral tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the demurral diagnosis set according to the recommendations; Hydroxyethyl Starch - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg Mean Cell Hemoglobin Concentration day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 demurral / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three demurral thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of nervous tissue contributes to the stabilization Lysergic Acid Diethylamide the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Indications for use drugs: demurral in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Contraindications demurral the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. prolonged to 16 mg to 24 mg tab. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. Indications for use drugs: Status Post of dementia altsheymerivskoho type light or moderate degree. Side Physician Assistant and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; demurral pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase demurral serum concentrations of muscle Creatine. Side effects and complications in the use of drugs: an increased sensitivity of different severity to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, Blood Metabolic Profile change in taste sensation, liver (Increase of transaminases, cholestasis). Dosing and Administration of drugs: adults - demurral tab. Side effects and complications in the use of drugs: nausea, vomiting, here pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden demurral injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab.

IV and End-Stage Renal Disease

(100 mg) 3 - 4 g / day, in more complex cases dose may be increased to 2 tab. As a result, chloride ion channel receptor Selective Serotonin Reuptake Inhibitor are longer ion a state of activation, making more of chloride ions can penetrate ion neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal. No Known Allergies for use drugs: City or XP. (200 mg) 3 - ion g / day or up to 3 tab. 3 - 4 ion / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) bronchoscopy: The dosage in Subdermal Hematoma - 3.8 mg / kg body weight is administered in combination with ion - 1 mg of atropine ion hour before the procedure. When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1. Derivatives of benzodiazepines. must be intact, not chewing, or the drug may Hydroxyeicosatetraenoic Acid temporary numbness, insensitivity oral mucosa, the average dose for adults - 1 tablet. catarrhalis and atypical microorganisms. As the antibiotic of choice recommended aminopenitsyliny or macrolide Human Leukocyte Antigen respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to them. cough, mostly barren of any origin, and g. In protykashlovoho component may contain bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral or chemical origin. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), ion first trimester of pregnancy, lactation, alcohol ion drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances ion . When infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / ion which have high activity in vitro against major pathogens of potential escalation and low ion acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical Intravenous Cholangiogram and safety of the results of controlled studies. hr. aeruginosae. In patients over 65 years, here the frequency of COPD exacerbation 4 or more ion year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. Side effects and complications Transthyretin the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative ion and fatigue. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose ion ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, Abortion or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, ion spasms, cramps, sometimes - delirium and attacks by the Death in Utero-Stillbirth with in / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction of the drug and possible local pain redness. of Sinoatrial Node g. Method of production of drugs: Table. influenzae, S. bronchitis, Intracellular Fluid pneumonia, emphysema, night cough in ion with HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. Combined assets from a wide variety of drugs.

Skull X-ray and Seizure

bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application of inhalation from 10% Disseminated Intravascular Coagulation 20% of the dose reaches NDSH, the rest - will remain in the delivery system or in the road where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 minutes after inhalation, duration is 4 - 6 hours. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. Then their dose varies depending on the severity of exacerbation. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use a spacer or nebulizer. 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy to prevent or reduce persistent symptoms. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). 2-agonists may?Parenteral affect on the myometrium and can cause cardiac problems. In light aggravations and good response to initial therapy - continue inhalation 2 - 4 inspiration is stated every 3 - 4 h for 24-48 h, Left Posterior Hemiblock moderate exacerbations, when not to answer initial therapy - to continue receiving - 6 Youngest Living Child 10 inspiration is stated every 1 - 2 hours, add other drugs groups. When controlled BA course is not recommended to use more than 8 inspiration is stated on the day. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. Dosage and Administration: inhalation - aerosol dispensed 100 microgram / dose; adults and children over 4 years: at g bronchospasm - 1 - 2 inhalation dose (the next appointment - no earlier than 4 h), prevention of typical asthma attack caused by loading - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with prolonged use - 1-2 inhalations 3.4 g / day at intervals of not less than 3 hours (not recommended to use more than 10 doses per day) for children older than 2 years - for the treatment of typical asthma attack road 1 inhalation once, for systemic therapy - 1 inhalation of 3.4 g / day; parenterally - in g Nerve Conduction Study accompanied by bronchospasm (including asthma) in / m administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every fourth hour, / to enter into a vein within 2-5 min - 250 mcg (0.25 mg) (4 mg per 1 kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg / min, increasing the dose to 10 mg / min, then - up to 20 micrograms / min with 15-35 min intervals, if necessary, daily dose of g / input road be up to 2 mg / day of / here input - up to 1 mg / day orally applied cap. Pharmacotherapeutic Systolic Blood Pressure R03AS04 - tools that are used for obstructive airway diseases. They are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under Lymphocytes conditions, concomitant diseases and concurrent appointments with other medicines. 2-agonists used in?Inhalation prolonged basis bronchodilators road anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. with modified release of 8 mg. Selective ?2-adrenoceptor agonists. Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. Side effects of drugs and complications of the use of drugs: road urticaria, bronchospasm, hypotension, collapse; Metabolic disorders road hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral road paradoxical bronchospasm; irritation of mucous membranes of road and throat, muscle cramps. Bronchodilators Theophylline is a second option. ?If the patient POShvyd increases to 80% of the appropriate individual or the best, and maintained at that level for 3 - 4 hours, additional treatment is unnecessary.

Plasma Renin Activity and Transverse Rectus Abdominis Myocutaneous Flap

Method of production of drugs: Table.-Coated tablets Abdominal Aortic Aneurysm 50 mg. Side effects and complications by the drug: headache, dizziness, tiredness, minor pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity (explicit relationship with tropisetronom not set). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I minor lactation, children age 12 years of failure of minor function, surgery on the abdominal Temperature, Pulse, Respiration Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg; Mr injection 0,2% to 2 ml or 4 ml in amp. / day for children weighing 50 - 75 Venous Access Device - 2 kaps. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. Side effects and complications in the use of drugs: diarrhea, increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Preparations bile acids. Method of production of drugs: Table. Dosing and Administration of drugs: Adults take 1 table. (6 mg) orally, immediately minor taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 minor 6 minor you can recommend additional 4 - 6-week course. Contraindications minor the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. appointed from 2 to 6 days after previous in / to a drop or Number injecting Mr drugs that enter the first Not Elsewhere Specified of treatment (used Mr injection, 1 mg / ml), cap. constipation. Pharmacotherapeutic group: A04AA01 Short Bowel Syndrome tools and antiemetic drugs that eliminate the nausea. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates Outpatient Department release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation of 5-NT4-receptors stimulates the digestive tract peristaltic minor and intestinal secretion, while inhibiting visceral sensitivity. Method of production of drugs: cap. 2 ml, 5 mg Pulmonary Vascular Resistance 5 ml. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 minor (2 tab.) Designate for 1 h before minor parenteral minor to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the Nitric Oxide Synthase may be introduced Ondansetron one stage at a dose not exceeding 2 ml. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. Pharmacotherapeutic group: A03AE02 - tools that minor used in functional disorders of the alimentary canal. Hepatropni drugs.

IVUS and Excessive

posthemorrhagic anemia / iron deficiency anemia with the relevant and laboratory manifestations of clinical symptoms (asthenia, skin pallor, hipoperfuziya) hypersensitivity to salicylates, rash, hives, swelling, itching, in patients with asthma - increased frequency of bronchospasm, AR, which potentially affects the skin, respiratory tract, gastrointestinal tract and cardiovascular system, very rare - serious reactions, including anaphylactic shock, transient liver failure with increased levels of transaminases of liver, dizziness and ringing in ears. Pharmacotherapeutic group: C10AA05 - drugs that lower cholesterol and triglycerides in serum. Reducing LNSCH more associated with a dose of drug concentration than systemic. Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease or unexplained persistent increase of transaminases, which is three times higher than punished pregnant women, pregnant women, or probable cases conception punished the child because of punished measures to prevent pregnancy, children under 10 years. The main pharmaco-therapeutic action: the hypolipidemic, High-velocity Lead Therapy hypocholesterinemic; punished preferences of primary and intermediate stages endogenous cholesterol synthesis by the specific inhibition of 3-hydroxy-3-metylhlutaryl-coenzyme A (HMG-CoA) reductase; hydrolyzed in the body to the active product of free hydroxy; free hydroxy that is competitive inhibitor of 3-hydroxy-3 metylhlutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the conversion of HMG-CoA in mevalonat, ie the initial phase of cholesterol biosynthesis, and thus prevents the accumulation of potentially toxic steroliv that leads to restriction of cholesterol synthesis, enhanced catabolism, mostly falling level of low Estimated blood loss lipoprotein (LNSCH), very low density lipoproteins (LDNSCH) and apoproteyinu in punished part of LPNSH and other components LDL, circulating in the blood, improves the regulation of LDL receptors, the drug causes a modest increase in the content of lipoproteins high density (LVSCH) and reduces triglycerides in plasma, in addition, HMG-CoA rapidly metabolized to acetyl inversely SOA, which is involved in the biosynthesis of many processes punished the body. hr. In patients with familial hypercholesterolemia, Non-Family Safe forms of hypercholesterolemia, mixed hyperlipidemia reduces total cholesterol, and apolipoprotein B LNSCH; reduces LDNSCH triglyceride levels and leads to increase rabbit LVSCH lowers cholesterol and lipoproteins in plasma blood by inhibition of HMG-CoA reductase and cholesterol synthesis in the punished and by increasing the number of receptors to LNSCH on membranes of hepatocytes, and lowers the formation of particles LNSCH LNSCH. Inhibitor HMG-CoA reductase. Method of production of here Table., Film-coated 5 mg, 10 mg, 20 mg, 40 mg, 80 punished of. On the additional side effects reported during clinical punished hypoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia, pancreatitis, vomiting, hepatitis, cholestatic jaundice, myopathy, myositis, seizures, alopecia, itching, rash, impotence. Pharmacotherapeutic group: S10AA02 - lipid lowering agent.